COV Stock Chart & Stats
AU$0.60
AU$0.02(5.80%)
At close: 4:00 PM EST
AU$0.60
AU$0.02(5.80%)
Day’s Range― - ―
52-Week RangeAU$0.34 - AU$0.90
Previous CloseN/A
Volume276.00
Average Volume (3M)154.50K
Market Cap
AU$48.67M
Enterprise ValueAU$43.65M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding137,112,090
10 Day Avg. Volume221,880
30 Day Avg. Volume154,495
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CLEO Diagnostics Ltd News
COV FAQ
What was CLEO Diagnostics Ltd’s price range in the past 12 months?
CLEO Diagnostics Ltd lowest share price was AU$0.34 and its highest was AU$0.90 in the past 12 months.
What is CLEO Diagnostics Ltd’s market cap?
CLEO Diagnostics Ltd’s market cap is AU$48.67M.
When is CLEO Diagnostics Ltd’s upcoming earnings report date?
CLEO Diagnostics Ltd’s upcoming earnings report date is Sep 02, 2026 which is in 42 days.
How were CLEO Diagnostics Ltd’s earnings last quarter?
CLEO Diagnostics Ltd released its earnings results on Feb 25, 2026. The company reported -AU$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.015.
Is CLEO Diagnostics Ltd overvalued?
According to Wall Street analysts CLEO Diagnostics Ltd’s price is currently Overvalued.
Does CLEO Diagnostics Ltd pay dividends?
CLEO Diagnostics Ltd does not currently pay dividends.
What is CLEO Diagnostics Ltd’s EPS estimate?
CLEO Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CLEO Diagnostics Ltd have?
CLEO Diagnostics Ltd has 137,112,090 shares outstanding.
What happened to CLEO Diagnostics Ltd’s price movement after its last earnings report?
CLEO Diagnostics Ltd reported an EPS of -AU$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.226%.
Which hedge fund is a major shareholder of CLEO Diagnostics Ltd?
Currently, no hedge funds are holding shares in AU:COV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CLEO Diagnostics Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.10%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
26.25%
Trailing 12-Months
Technical Analysis
BCAL Diagnostics Limited
―
Atomo Diagnostics Ltd.
―
Lumos Diagnostics Holdings Ltd.
―
Proteomics International Laboratories Ltd.
―
Genetic Signatures Ltd.
―







